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Theoretical quantitative evaluation of the intercalative binding to DNA of the new antitumor drug 9-amino- 
acridine-4-carboxamide indicates that, in contradiction with a recently proposed model, the compound 
should show specificity for interaction with the major (and not minor) groove of GC sequences. 
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1. INTRODUCTION 
9-Aminoacridine-4-carboxamide (I) is the parent 
compound of a new class of antitumor agents with 
promising activity [1]. As a number of other an- 
titumor agents it acts by intercalating into DNA, in 
which it binds selectively to its GC sequences [1]. 
In a recent attempt to establish a more precise 
definition of the selectivity of binding, Wakelin et 
al. [1] have investigated the kinetics of dissociation 
of calf thymus DNA complexes of I using the 
surfactant-sequestration method. The results led 
them to propose that the biologically significant 
decationic form of I (one proton on the ring 
nitrogen and the other on the terminal nitrogen of 
the side chain) should intercalate from the minor 
groove of the GC base pair. This proposal was bas- 
ed on the assumption [2] that "the electrostatic 
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potential is greater in the minor compared to the 
major groove in B-type DNA"  and on examples of 
other complexes (e.g. daunomycin-DNA) in which 
the bulk of the ligand attached to the intercalating 
chromophore resides in the minor groove. 
None of these two arguments seems atisfactory 
enough to justify the proposal of the minor groove 
intercalation of I. In the first place, the estimation 
that the electrostatic potential is greater in the 
minor compared to the major groove in B-type 
DNA is incomplete. While this is so in AT se- 
quences the situation is reversed in GC sequences, 
in which the greatest electrostatic molecular poten- 
tial resides in the major groove [3,4]. In the second 
place, intercalators with bulk ligands attached to 
them, may well have these ligands located in the 
major as well as in the minor groove. Thus, the 'se- 
cond generation' anthracyclines, mitoxantrone 
and anthrapyrazole, while showing a definite 
specificity for intercalation between GC base pairs, 
have their side chains located in the major groove 
[5,61. 
For these reasons and in view of the potential 
importance of this new type of drug as an an- 
titumor agent, we have carried out an explicit com- 
putation on the stereochemistry of the intercalative 
Published by Elsevier Science Publishers B.V. (Biomedical Division) 
00145793/87/$3.50 © 1987 Federation of European Biochemical Societies 361 
Volume 224, number 2 FEBS LETTERS November 1987 
H2 
43 44 ~5 +/~6H3 
- -~H- -CH2- -CH2- -N .  
II H \  ~;'H 3 
O 
are entirely analogous to those used in our studies 
on the interaction with ol igomeric sequences of  
daunomycin  [7], adr iamycin [8], mitoxantrone [5] 
and anthrapyrazole [6] and will thus not be 
repeated here. Fig.1 recalls the base numbering in 
the investigated tetramers,  the intercalat ion occur- 
ring between bases 2-3' and 3-2 ' .  
C4 . . . . .  GI'. 
P3 "~.PI' ~ G3 . . . . .  C2 ¢/ 
P2 ~P2 '  
~C2 . . . . .  G3 k 
P1 /  /P3 '  
\O~ . . . . .  c4' I 3 ' 
i T4  . . . . .  AI' P3 ~P I '  
~A3 . . . .  -T2' .  / % 
P2~T2 . . . . .  A3,//P2, 
P1 ~I . . . .  -'I',,4 '~P3'' 
Fig.1. Base numbering in the model tetramers. 
Intercalation occurs between bases 2-3' and 3-2'. 
interact ion of  the dicationic form of  I with 
tetrameric alternating AT and GC sequences in the 
B -DNA conformat ion.  The method and procedure 
2. RESULTS AND DISCUSSION 
The interaction energies for the intercalat ion of  
I into the ol igomers d(GCGC)2 and d(ATAT)z,  in 
the major  and minor grooves, are listed in table 1. 
In this table AE represents the intermolecular in- 
teract ion energy, the components of  which are also 
listed: electrostatic, EMTr'; polar isat ion,  Epoi; 
charge transfer,  Ec,; dispersion, Odisp; repulsion, 
Erep. AEconf represents the conformat ional  energy 
modi f icat ion of  the l igand with respect o its intrin- 
sically most stable form in the free state. ~Euns,ack 
is the energy necessary to generate the intercalat ion 
site (in conformity  with experimental  indications 
[1] an unwinding angle of  16 ° was adopted for this 
case), dE = AE  + ~Econf + ~Eunstack represents the 
overal l  energy balance for the interaction and c~ the 
relative energies of  the different associations with 
respect o the most stable one taken as zero energy. 
The results clearly conf irm the GC specificity of  
the drug but indicate at the same time, in contrast 
Table 1 
Values of the intercalative interaction energies (in kcal/mol) of 
compound I in the major and minor groove of sequences d(GCGC)2 and 
d(ATAT)z (see text for definitions) 
Major groove Minor groove 
d(GCGC)2  d(ATAT)2  d(GCGC)2 d(ATAT)2 
AE -544.2 --526.7 -504.8 --512.1 
EMTp --497.9 --480.7 --451.0 --458.3 
Epol - 38.0 - 37.5 - 33.9 - 32.3 
EcT -- 11.2 --7.1 --5.4 --3.7 
Edisp -- 77.4 - 83.4 - 78.1 - 67.6 
Erep 80.4 82.1 63.5 49.9 
c~Eco,f. 12.8 8.6 8.1 6.7 
~Eunstack 4.1 5.2 4.1 5.2 
c~E - 527.3 512.9 - 492.6 - 500.2 
c~ 0.0 14.4 34.7 27.1 
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to the proposal of [1], a clear-cut preference for 
the location of the side chain in the major groove 
of these sequences. It can be seen that this 
preference is determined essentially by the elec- 
trostatic term of the interaction energy. 
A detailed analysis of the stereochemistry of the 
association enables one to pinpoint the essential 
structural features involved in the preferential 
binding. Table 2 indicates the main hydrogen- 
bonding contacts established between the drug and 
the oligomer for the different modes of assoca- 
tions. It is easily seen that the most significant in- 
teractions occur for binding in the major groove of 
the GC sequence. In the optimized conformation 
the long axis of the chromophore is at an angle of 
about 30 ° to the long axis of the base pairs of the 
intercalation site. In this way the compound can 
strongly bind to the two strands of the 
tetranucleotide, the 4-carboxamide side chain bin- 
ding to one and the 9-NH2 group to the other. 
The stabilization of the complexes in the major 
groove of d(GCGC)2 and d(ATAT)2 is ensured by 
interactions involving: 
(i) A hydrogen bond between the H atom of the 
ammonium nitrogen N45 and an oxygen of the 
phosphate of the primed strand at the intercalation 
site, O1(P2') (dH-o = 1.58-1.77 A); 
Table 2 
Interatomic distances (in ,/~) in the complex of compound 1 with d(GCGC)z and d(ATAT)z 
Major groove Minor groove 
d(GCGC)z d(ATAT)2 d(GCGC)z d(ATAT)2 
H(N45)-Ol(P2') H(N45)-Ol(P2') H(N45)-O3, (S-G3) 
1.58 1.77 2.54 
-03, (S-T2') -O1, (S-G3) 
2.95 2.76 
H2(C44)-NT(G3 ' ) Hz(C44)-O1(P2' ) H l(C44)--Ol, (S-G3) 
2.27 2.36 2.02 
H3(C46)-Nv(G3') Hz(C46)-OI(P2') Ht(C47)-N3(G3) 
2.36 2.81 2.25 
H3(C46)-Nv(A3 ') -O l '  (S-G3) 
2.53 2.96 
H2(C47)-N3(G3) 
2.79 
H(N42)-O6(G3 ' ) H(N42)-Nv(A3 ' ) H(N42)-Nz(G3 ' ) 
2.56 2.27 2.87 
O41-Hl(N4-C2' ) 041-Hz(N2-G3) 
2.79 2.62 
-H2(N4-C2 ' ) 
2.83 
H l(N9)-O1, (S-G3) 
2.78 
H2(N9)-O5 ,(S-G3) 
1.99 
-Ol(P2) 
2.66 
-Ol  ,(S-G3) 
2.72 
HI(N9)-Ot' (S-A3) 
2.60 
Hz(N9)-Os' (S-A3) 
2.01 
-O l '  (S-A3) 
2.41 
H(N45)-O~, (S-T4) 
2.13 
H 1(C44)-O1 ' (S-A3) 
2.34 
-N3(A3) 
2.42 
Hz(C44)-O~' (S-A3) 
2.20 
Hl(C47-N3(A3) 
2.88 
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(ii) Hydrogen bonds between H atoms of C44, 
C46 and C47, on which part of the positive charge 
of the trimethylammonium moiety is delocalized, 
and N7 of guanine (or adenine) and the oxygen of 
the phosphate of the intercalation site (dn-N or 
dia-o = 2.27-2.81 A); 
(iii) A hydrogen bond between H of N42 and 06 
of guanine or N7 of adenine (dH-N or dH-o = 
2.27-2.56 A); 
(iv) A hydrogen bond between the H atom of the 
9-NH2 group of I and the oxygen atoms O1, and 
05, of the sugar linked to base G3 or A3, and O1 
of the phosphate of the unprimed strand, in the in- 
tercalation site (dH-o = 1.99-2.72 A). 
From table 2 it can be seen that these hydrogen 
bonds are stronger with d(GCGC)2 than with 
d(ATAT)2. Furthermore, there is an additional in- 
teraction in the complex with d(GCGC)2 between 
the oxygen of the carboxamide, O41 and the H of 
the NH2 group of cytosine C2' (dH-o = 
2.79-2.85 .~), which does not exist in the complex 
with d(ATAT)2. As a result, the interaction energy 
is significantly more favourable for the complex 
with d(GCGC)2 than with d(ATAT)2. 
As to the hydrogen-bonding interactions in the 
hypothetical complexes in the minor groove of the 
oligonucleotides they are obviously less numerous 
and less efficient than those occurring for interac- 
tion in the major groove. 
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